Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint

A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Donepezil Transdermal Delivery System

A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Effects of SAGE-718 in Patients with Alzheimer's Disease: Study Design